Product Overview
Scientists recognize the CJC-1295 (No DAC) + Ipamorelin 20mg blend as a premier tool for endocrine research. This dual-peptide stack targets growth hormone pathways from two distinct angles. Specifically, it combines a GHRH analog with a ghrelin receptor agonist. Consequently, this synergy creates a significantly more potent biological response than single-peptide applications.
We supply this preparation as a 20mg total lyophilized powder in a sealed research vial. This process effectively preserves peptide stability during transport. Therefore, researchers can reconstitute the blend easily for precise in vitro experimentation. Because of its stable analytical profile, this blend is a staple in modern biochemical signaling studies.
Product Features and Specifications
We manufacture our CJC-1295 + Ipamorelin blend to meet the highest industry standards. This ensures laboratory-grade results for every study.
- Total Content: 20mg per vial (CJC-1295 (no dac) 10mg + Ipamorelin 10mg)
- Purity: ≥98% (HPLC Verified).
- Format: High-purity lyophilized powder in a sterile research vial.
- Stability: Optimized for long-term shelf life and structural integrity.
- Appearance: White to off-white lyophilized cake.
The Power of Peptide Synergy
In clinical research models, the combination of CJC-1295 and Ipamorelin has demonstrated remarkable results. Notably, studies show this blend can produce five times the benefits of either peptide used alone.
Primary Research Applications
In controlled laboratory environments, scientists utilize this dual blend for various experimental models. Specifically, examples include:
- Signaling Investigation: Mapping peptide-mediated endocrine pathways.
- Receptor Interaction: Studying the binding dynamics of GHRH and Ghrelin receptors.
- Intracellular Modeling: Creating networks to simulate complex hormonal regulation.
- Comparative Studies: Evaluating the synergy of stacked analogs vs. isolated compounds.
- In Vitro Research: Conducting controlled experiments on live cell cultures.
CJC-1295 No DAC (MOD GRF 1-29)
CJC-1295 No DAC is a synthetic analog of Growth Hormone Releasing Hormone (GHRH). It functions by activating growth hormone receptors directly. Consequently, researchers study this peptide to investigate:
- Muscle Growth: Analyzing lean tissue accrual and repair.
- Metabolic Function: Exploring fat burning and glucose regulation.
- Systemic Recovery: Investigating wound healing and bone strength.
Ipamorelin
Ipamorelin is a selective ghrelin receptor mimetic. Unlike other secretagogues, it triggers a specific growth hormone pulse without increasing cortisol or prolactin. Furthermore, extensive research indicates that Ipamorelin may:
- Enhance Bone Health: Supporting research into bone mineral density.
- Improve Gastric Function: Analyzing bowel motility and pancreatic insulin release.
- Optimize Muscle Maintenance: Investigating nitrogen retention in cellular models.
Reviews
There are no reviews yet.